Meiner V, Landsberger D, Berkman N, Reshef A, Segal P, Seftel H C, van der Westhuyzen D R, Jeenah M S, Coetzee G A, Leitersdorf E
Department of Internal Medicine B, Hadassah University Hospital, Jerusalem, Israel.
Am J Hum Genet. 1991 Aug;49(2):443-9.
Familial hypercholesterolemia (FH) is an autosomal dominant disease caused by mutations in the low-density-lipoprotein (LDL) receptor. Here we characterize an LDL-receptor founder mutation that is associated with a distinct LDL-receptor haplotype and is responsible for FH in 35% of 71 Jewish-Ashkenazi FH families in Israel. Sixty four percent (16/25) of the Ashkenazi patients who carry this mutant allele were of Lithuanian origin. The mutation was not found in 47 non-Ashkenazi FH families. This mutation was prevalent (8/10 FH cases) in the Jewish community in South Africa, which originated mainly from Lithuania. The mutation, a 3-bp in-frame deletion that would result in the elimination of Gly197, has been previously designated FH-Piscataway. PCR amplification of a DNA fragment that includes the mutation in heterozygous individuals results in the formation of a heteroduplex that can be demonstrated by PAGE and used for molecular diagnosis.
家族性高胆固醇血症(FH)是一种由低密度脂蛋白(LDL)受体突变引起的常染色体显性疾病。在此,我们鉴定了一种LDL受体的始祖突变,该突变与一种独特的LDL受体单倍型相关,并且在以色列71个犹太-阿什肯纳兹FH家族中的35%中导致FH。携带这种突变等位基因的阿什肯纳兹患者中有64%(16/25)来自立陶宛。在47个非阿什肯纳兹FH家族中未发现该突变。这种突变在南非主要源自立陶宛的犹太社区中很普遍(10例FH病例中有8例)。该突变是一个3个碱基对的框内缺失,会导致Gly197缺失,此前被命名为FH-皮斯卡塔韦。对杂合个体中包含该突变的DNA片段进行PCR扩增会形成异源双链体,可通过聚丙烯酰胺凝胶电泳(PAGE)显示并用于分子诊断。